510(k) Report

510(k) · Cleared

Cleared

Aesculap Angled Neuroendoscopes

K964281510(k) TraditionalCleared Apr 21, 1997175-day reviewClass II21 CFR 882.1480

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aesculap, Inc. · GWG Endoscope, Neurological

Cleared on Apr 21, 1997 after a 175-day review. The FDA summary names its predicate without a number. 43 later devices descend from it.

Decided
Apr 21, 1997
Review
175 days
Class
Class II
Product code
GWG
Recalls
None
Predicates
0

43 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 3 descendants cleared2013: 1 descendant cleared2014: 1 descendant cleared2017: 4 descendants cleared2015: 1 descendant cleared2016: 1 descendant cleared2022: 5 descendants cleared2018: 1 descendant cleared2024: 4 descendants cleared2021: 3 descendants cleared2020: 2 descendants cleared2026: 8 descendants cleared2023: 6 descendants cleared2025: 3 descendants cleared1995200020052010201520202025
  1. This deviceK964281 Aesculap Angled NeuroendoscopesAesculap, Inc. · 1997
  2. Descendant · cites it directly · 42 of its ownK081102 Vsu - Visionsense Stereoscopic Vision SystemVisionsense, Ltd. · 2008 · Recalled
  3. Descendant · 2 generations on · 38 of its ownK131434 VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd. · 2013
  4. Descendant · 2 generations on · 37 of its ownK082355 Visionsense Stereoscopic Vision SystemVisionsense, Ltd. · 2008
  5. Descendant · 3 generations on · 36 of its ownK141002 VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd. · 2014
  6. Descendant · 3 generations on · 34 of its ownK152204 VS3-IR systemVisionsense, Ltd. · 2015

Showing 5 of 43 descendants. See all descendants

Descendants cleared per year

2008: 32013: 12014: 12015: 12016: 12017: 42018: 12020: 22021: 32022: 52023: 62024: 42025: 32026: 8
2008high 8 (2026) · low 0 (2009)2026

Most influential descendants

Showing 5 of 43 · See all
  • K081102Vsu - Visionsense Stereoscopic Vision SystemVisionsense, Ltd. · 2008 · cites it directly42descendants
  • K131434VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd. · 2013 · 2 generations on38descendants
  • K082355Visionsense Stereoscopic Vision SystemVisionsense, Ltd. · 2008 · 2 generations on37descendants
  • K141002VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd. · 2014 · 3 generations on36descendants
  • K152204VS3-IR systemVisionsense, Ltd. · 2015 · 3 generations on34descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K964281Aesculap Angled NeuroendoscopesAesculap, Inc.1997—
+1K081102Vsu - Visionsense Stereoscopic Vision SystemVisionsense, Ltd.20081
+2K131434VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd.2013—
+2K082355Visionsense Stereoscopic Vision SystemVisionsense, Ltd.2008—
+3K141002VS3 Stereoscopic High Definition Vision SystemVisionsense, Ltd.2014—
+3K152204VS3-IR systemVisionsense, Ltd.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200830
201310
201410
201510
201610
201740
201810
202020
202130
202250
202360
202440
202530
202680
FIG. 1 — Lineage of K964281, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWG device

  1. #1 K211202 1688 4K Camera System, L11 LED Light Source…score 22.5 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Aesculap Neuroendoscope
Named without a submission number
—
*—Aesculap Endoscopes
Named without a submission number
—
*—Codman Neuroendoscopes
Named without a submission number
—

What descends from it? (43)

See all 43

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081102Vsu - Visionsense Stereoscopic Vision SystemVisionsense, Ltd.200842

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K081102 (Visionsense, Ltd., 2008) has gone furthest, with 42 descendants of its own.

How does its category compare?

All GWG devices

GWG Endoscope, Neurological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GWG

2in 2025

2008: 22013: 12014: 22016: 22017: 42018: 42019: 32020: 22021: 32023: 52024: 12025: 22026 (partial year): 4
2007high 5 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWG

269in 2023

2017: 126 days median2018: 128 days median2019: 156 days median2021: 106 days median2023: 269 days median2026 (partial year): 217 days median
2007high 269 (2023) · low 106 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWG

2in 2011

2009: 12011: 2
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWG

33in 2025

2007: 32008: 52010: 12011: 42012: 72013: 32014: 192015: 372016: 252017: 122018: 162019: 102020: 192021: 212022: 122023: 92024: 92025: 33
2007high 37 (2015) · low 0 (2009)2025

MAUDE reports naming product code GWG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20082—05
20090—10
20100—01
20110—24
20120—07
20131—03
20142—019
20150—037
20162—025
20174126012
20184128016
20193156010
20202—019
20213106021
20220—012
2023526909
20241—09
20252—033
202642170—

What is it indicated for?

Aesculap’s Angled Neuroendoscopes are intended for use in visualization of ventricles and structures within the brain.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964281: Aesculap Angled Neuroendoscopes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K964281

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026